Brandes Investment Partners’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$57.4M Buy
3,712,278
+208,136
+6% +$3.22M 0.52% 67
2025
Q1
$52.1M Buy
3,504,142
+464,557
+15% +$6.91M 0.53% 66
2024
Q4
$40.2M Sell
3,039,585
-192,019
-6% -$2.54M 0.45% 70
2024
Q3
$46M Buy
3,231,604
+596,577
+23% +$8.48M 0.52% 65
2024
Q2
$34M Sell
2,635,027
-267,480
-9% -$3.46M 0.42% 69
2024
Q1
$40.3M Buy
2,902,507
+251,242
+9% +$3.49M 0.52% 62
2023
Q4
$37.8M Buy
2,651,265
+849,229
+47% +$12.1M 0.57% 59
2023
Q3
$27.9M Buy
1,802,036
+36,717
+2% +$568K 0.54% 59
2023
Q2
$27.7M Sell
1,765,319
-52,653
-3% -$827K 0.56% 55
2023
Q1
$30M Buy
1,817,972
+1,699,552
+1,435% +$28M 0.64% 49
2022
Q4
$1.85M Sell
118,420
-1,752,623
-94% -$27.3M 0.05% 95
2022
Q3
$24.3M Sell
1,871,043
-151,504
-7% -$1.96M 0.63% 45
2022
Q2
$28.4M Sell
2,022,547
-87,299
-4% -$1.23M 0.69% 44
2022
Q1
$30.2M Buy
2,109,846
+360,083
+21% +$5.16M 0.65% 45
2021
Q4
$23.9M Sell
1,749,763
-266,061
-13% -$3.63M 0.52% 56
2021
Q3
$33M Sell
2,015,824
-66,411
-3% -$1.09M 0.72% 48
2021
Q2
$35M Buy
2,082,235
+321,387
+18% +$5.41M 0.78% 43
2021
Q1
$32.3M Buy
1,760,848
+97,767
+6% +$1.79M 0.76% 44
2020
Q4
$30.2M Buy
1,663,081
+208,042
+14% +$3.78M 0.78% 46
2020
Q3
$26M Sell
1,455,039
-215,770
-13% -$3.85M 0.9% 41
2020
Q2
$30M Sell
1,670,809
-127,430
-7% -$2.28M 0.91% 41
2020
Q1
$27.3M Buy
1,798,239
+84,890
+5% +$1.29M 0.96% 39
2019
Q4
$33.8M Sell
1,713,349
-129,886
-7% -$2.56M 0.8% 41
2019
Q3
$31.7M Buy
1,843,235
+499,819
+37% +$8.6M 0.82% 44
2019
Q2
$23.8M Sell
1,343,416
-133,599
-9% -$2.36M 0.53% 55
2019
Q1
$30.1M Buy
1,477,015
+463,133
+46% +$9.43M 0.7% 47
2018
Q4
$17.1M Buy
+1,013,882
New +$17.1M 0.43% 61